Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

Historic Gross Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 100.0%.

  • ENDRA Life Sciences' Gross Margin changed N/A to 100.0% in Q1 2018 from the same period last year, while for Dec 2018 it was 100.0%, marking a year-over-year increase of 491400.0%. This contributed to the annual value of 100.0% for FY2018, which is 491400.0% up from last year.
  • As of Q1 2018, ENDRA Life Sciences' Gross Margin stood at 100.0%.
  • ENDRA Life Sciences' Gross Margin's 5-year high stood at 100.0% during Q1 2018, with a 5-year trough of 10.98% in Q2 2017.
  • Over the past 3 years, ENDRA Life Sciences' median Gross Margin value was 54.96% (recorded in 2017), while the average stood at 55.8%.
  • The largest annual percentage gain for ENDRA Life Sciences' Gross Margin in the last 5 years was 7100bps (2017), contrasted with its biggest fall of 7100bps (2017).
  • Quarter analysis of 3 years shows ENDRA Life Sciences' Gross Margin stood at 54.25% in 2016, then grew by 1bps to 54.96% in 2017, then soared by 82bps to 100.0% in 2018.
  • Its Gross Margin stands at 100.0% for Q1 2018, versus 54.96% for Q4 2017 and 58.79% for Q3 2017.